Current advances in modulating tumor hypoxia for enhanced therapeutic efficacy

Area of Science:

• Oncology
• Nanotechnology
• Biomedical Engineering

Background:

• Hypoxia is prevalent in solid tumors, driving tumor progression, invasion, metastasis, and therapeutic resistance.
• Developing strategies to overcome tumor hypoxia is crucial for enhancing cancer treatment efficacy.
• Nanoplatforms offer advanced solutions for modulating the tumor microenvironment.

Purpose of the Study:

• To review the impact of tumor hypoxia on cancer development and treatment resistance.
• To systematically summarize current nanoplatform strategies for modulating tumor hypoxia.
• To provide insights into future clinical applications for treating hypoxic tumors.

Main Methods:

• Literature review of research on tumor hypoxia and nanomedicine.
• Categorization of nanoplatform strategies into hypoxia-overcoming, hypoxia-exploiting, and hypoxia-disregarding approaches.
• Discussion of the rationale, research progress, and clinical prospects of these strategies.

Main Results:

• Hypoxia significantly promotes tumor proliferation, invasion, metastasis, and resistance to therapy.
• Various nanoplatforms are being developed to target tumor hypoxia, including those that overcome, exploit, or disregard hypoxic conditions.
• Detailed analysis of the mechanisms and advancements in nanoplatform-based hypoxia modulation.

Conclusions:

• Nanoplatforms hold significant promise for overcoming tumor hypoxia and improving cancer therapy outcomes.
• Understanding hypoxia-specific nanostrategies can guide the development of more effective treatments for solid tumors.
• Further research and clinical translation are needed to fully realize the potential of these advanced therapeutic approaches.